Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Ceska Gynekol ; 83(6): 434-439, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30848148

RESUMO

OBJECTIVE: The objective of this study was to investigate the clinical and epidemiological characteristics of patients with ectopic pregnancy admitted to a tertiary center in the Northeast Region of Brazil and the aspects related to the treatment and outcomes in these women. DESIGN: This was a retrospective cohort study of 101 patients diagnosed with ectopic pregnancy between February 2016 and February 2017. SETTING: Assis Chateaubriand Maternity School, Fortaleza, Ceará, Brazil Methods: The data collected included demographic characteristics, gynecological-obstetric history, symptoms at admission, complementary examinations [chorionic gonadotropin (β-hCG) blood test, transvaginal ultrasound, and hemoglobin level], and treatment given. RESULTS: The mean patient age was 28 ± 6.6 years (14-48 years). Abdominal pain (96%) and vaginal bleeding (82.4%) were the most prevalent symptoms. No risk factors were identified in most of the patients (53.5%), whereas the most frequently identified risk factor (16.9%) was a history of previous ectopic pregnancy. At admission, 63.4% of patients presented ruptured ectopic pregnancy and 5.9% had hemodynamic instability. Among the patients with ruptured ectopic pregnancy, 61% had already sought care at another center. With regard to the therapeutic options, 78.2% underwent surgery (27.2%, laparoscopy), 16.8% used methotrexate (MTX), and 5% underwent expectant management. Among those who received MTX, 41.2% needed subsequent surgery because of elevated blood β-hCG level (57.1%) and clinical signs of ruptured ectopic pregnancy (42.9%). CONCLUSION: The patients were admitted at an advanced stage of ectopic pregnancy, which made a more conservative and less costly treatment difficult. However, the outcomes were clinically satisfactory, with low complication rates and no maternal deaths. Keywords ectopic pregnancy, methotrexate, epidemiology, laparoscopy, laparotomy.


Assuntos
Dor Abdominal/etiologia , Gonadotropina Coriônica Humana Subunidade beta/sangue , Metotrexato/administração & dosagem , Gravidez Ectópica/tratamento farmacológico , Gravidez Ectópica/cirurgia , Hemorragia Uterina/etiologia , Dor Abdominal/epidemiologia , Brasil , Estudos de Coortes , Feminino , Humanos , Laparoscopia , Gravidez , Gravidez Ectópica/metabolismo , Prevalência , Estudos Retrospectivos , Resultado do Tratamento , Hemorragia Uterina/epidemiologia
2.
Pharmacology ; 86(4): 231-9, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20881447

RESUMO

BACKGROUND/AIMS: Antidepressants are reported to exhibit antiinflammatory effects. However, mechanisms involved in this action have not been elucidated. Thus, the objectives of the present study were (a) to evaluate the effects of amitriptyline on the acute inflammatory process, and (b) to investigate the participation of α(1)-adrenergic receptors and glucocorticoids as possible mechanisms implicated in the amitriptyline action on inflammation. METHODS AND RESULTS: Single and multiple doses of amitriptyline were administered to rats submitted to the carrageenan-induced paw edema model. The results showed a significant antiedematous reaction to amitriptyline, mainly when administered at each elimination half-life. The next step was to evaluate its effects on leukocyte behavior, using intravital microscopy. Amitriptyline produced a significant effect on leukocyte behavior. To investigate possible mechanisms involved, a glucocorticoid receptor antagonist (RU-486) and an α(1)-adrenergic receptor antagonist (prazosin) were used. RU-486 administration lacked the ability to decrease the amitriptyline antiinflammatory effects in the carrageenan-induced paw edema model. Prazosin pretreatment potentiated the amitriptyline antiinflammatory effect without presenting an effect per se. CONCLUSION: The present study shows the ability of amitriptyline to decrease edema and affect leukocyte behavior in an acute inflammatory process; and, for the first time to our knowledge, we suggest the involvement of α(1)-adrenoceptors in the antiinflammatory effects of amitriptyline.


Assuntos
Amitriptilina/farmacologia , Anti-Inflamatórios/farmacologia , Inflamação/tratamento farmacológico , Receptores Adrenérgicos alfa 1/efeitos dos fármacos , Amitriptilina/administração & dosagem , Amitriptilina/farmacocinética , Animais , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/farmacocinética , Carragenina , Modelos Animais de Doenças , Edema/tratamento farmacológico , Edema/fisiopatologia , Meia-Vida , Inflamação/fisiopatologia , Leucócitos/efeitos dos fármacos , Leucócitos/metabolismo , Masculino , Microscopia/métodos , Ratos , Ratos Wistar , Receptores Adrenérgicos alfa 1/metabolismo , Receptores de Glucocorticoides/efeitos dos fármacos , Receptores de Glucocorticoides/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA